This Committee Opinion states ACOG’s recommendations for screening and treatment of opioid use during pregnancy. Pregnancy provides an important opportunity to identify and treat women with substance use disorders, Universal screening for substance use should be a part of comprehensive obstetric care and should be done at the first prenatal visit in partnership with the pregnant woman. Multidisciplinary long-term follow-up should include medical, developmental, and social support. Infants born to women who used opioids during pregnancy should be monitored for neonatal abstinence syndrome by a pediatric care provider. Early universal screening, brief intervention (such as engaging a patient in a short conversation, providing feedback and advice), and referral for treatment of pregnant women with opioid use and opioid use disorder improve maternal and infant outcomes.
American College of Obstetricians and Gynecologists (ACOG), 2017
Evidence Rating: III